Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

The screening process of MN705. by Wencheng Jin (13136262)

Subjects:

Changes of anti-oxidative enzyme and oxidative stress after in a mouse model of kidney fibrosis. by Wencheng Jin (13136262)

Subjects:

Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

Subjects:

Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

Subjects:

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Subjects:

Hospital admissions and deaths for AMI two years before and one year after the earthquake by age and sex. Comparisons between observed events (one year after the EQ) and expected o... by Chiara Cadeddu (12554994)

Subjects:

Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

Subjects:

Data cleaning and preparation algorithm. by Ayana Ablayeva (22103708)

Subjects:

Anonymized data set. by Jonathan Nadjiri (665209)

Subjects:

Patient characteristics and procedural data. by Jonathan Nadjiri (665209)

Subjects:

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. positive controls Cisplatin and doxorubicin against other malignancy’ cell lines ad... by MohammedBashar Al-Qazzan (22439236)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in global men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of the number of incidence, prevalence, deaths and DALYs counts by age group and their crude ratios in China in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of ASIR, ASPR, ASMR and ASDR trends in China and global RA from 1990 to 2021. by Zhengpeng Li (2322058)

Subjects:

Global comparison of incidence, prevalence, deaths and DALYs counts by age group and their crude rates, 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of all–age cases with age–standardized incidence, prevalence,deaths, and DALYs in Chinese men and women, 1990–2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 2021. by Zhengpeng Li (2322058)

Subjects:

All–age cases and age–standardised incidence, prevalence, mortality, DALYs and corresponding AAPC for RA in China and world in 1990 and 2021. by Zhengpeng Li (2322058)

Subjects:

Comparison of RA incidence, prevalence, death and DALYs among men and women of different age groups in China in 1990. by Zhengpeng Li (2322058)

Subjects: